Comparison of the hypothalamic-pituitary-adrenal axis suscepibility upon single-dose i.m. depot versus long-acting i.v. triamcinolone acetonide therapy: A direct pharmacokinetic correlation

Journal of Endocrinology

Volumn 191, Issue 2, 2006, Pages 491-496

  Abraham, Getu ^a   Demiraj, Fioralba ^a   Ungemach, Fritz Rupert ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GLUCOCORTICOID; HYDROCORTISONE; LONG ACTING DRUG; TRIAMCINOLONE ACETONIDE; TRIAMCINOLONE ACETONIDE 21 DIHYDROGEN PHOSPHATE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTEROID THERAPY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG ELIMINATION; DRUG HALF LIFE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MEAN RESIDENCE TIME; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SINGLE DRUG DOSE;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; DELAYED-ACTION PREPARATIONS; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MALE; PITUITARY-ADRENAL SYSTEM; RANDOM ALLOCATION; TRIAMCINOLONE ACETONIDE;

EID: 33751521852     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06991     Document Type: Article

References (38)

1. Abraham G, Gottschalk J & Ungemach FR 2005 Evidence for ototopical glucocorticoid-induced decrease in hypothalamic-pituitary-adrenal axis response and liver function. Endocrinology 146 3163-3171.
2. Antoni FA 1986 Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocrine Reviews 7 351-378.
3. Bachert C, Lukat KF & Lange B 2004 Effect of intranasal fluticasone propionate and triamcinolone acetonide on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity in healthy volunteers. Clinical and Experimental Allergy 34 85-90.
4. BaxterJD 2000 Advances in glucocorticoid therapy. Advances in Internal Medicine 45 317-349.
5. Carson T, Daane TA & Weinstein RL 1975 Long-term intramuscular administration of triamcinolone acetonide. Effect on the hypothalamic-pituitary-adrenal axis. Archives of Dermatology 111 1585-1587.
6. Dallman MF, Akana SF, Jacobson L, Levin N, Cascio CS & Shinsako J 1987 Characterization of corticosterone feedback regulation of ACTH secretion. Annals of the New York Academy of Sciences 512 402-414.
7. Dallman MF, Akana SF, Levin N, Walker CD, Bradbury MJ, Suemaru S & Scribner KS 1994 Corticosteroids and the control of function in the hypothalamo-pituitary-adrenal (HPA) axis. Annals of the New York Academy of Sciences 746 22-31.
8. Derendorf H, Hochhaus G, Rohatagi S, Möllmann H, Barth J, Sourgens H & Erdmann M 1995 Pharmacokinetics of triamcinolone acetonide after intravenous, oral, and inhaled administration. Journal of Clinical Pharmacology 35 302-305.
9. Doggrell SA 2001 Triamcinolone: new and old indications. Expert Opinion on Pharmacotherapy 2 1177-1186.
10. French K, Pollitt CC & Pass MA 2000 Pharmacokinetics and metabolic effects of triamcinolone acetonide and their possible relationships to glucocorticoid-induced laminitis in horses. Journal of Veterinary Pharmacology and Therapeutics 23 287-292.
11. Gillies MC, Simpson JM, Luo W, Penfold P, Hunyor AB, Chua W, Mitchell P & Billson F 2003 A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Archives of Ophthalmology 121 667-673.
12. Gulliver T & Eid N 2005 Effects of glucocorticoids on the hypothalamic-pituitary-adrenal axis in children and adults. Immunology and Allergy Clinics of North America 25 541-555.
13. Heinzel G, Woloszczak R & Thomann P 1993 Topfit, Version 2.0. Pharmacokinetic and Pharmacodynamic Data Analysis System for the PC. Stuttgart, Jena, New York: Gustav Fischer-Verlag.
14. Heun R, Sliwka U, Ruttinger H & Schimrigk K 1992 Intrathecal versus systemic corticosteroids in the treatment of multiple sclerosis: results of a pilot study. Journal of Neurology 239 31-35.
15. Hoffmann V, Kuhn W, Schimrigk S, Islamova S, Hellwig K, Lukas C, Brune N, Pohlau D, Przuntek H & Muller T 2006 Repeat intrathecal triamcinolone acetonide application is beneficial in progressive MS patients. European Journal of Neurology 13 72-76.
16. Iglesias P, Gonzalez J & Diez JJ 2005 Acute and persistent iatrogenic Cushing's syndrome after a single dose of triamcinolone acetonide. Journal of Endocrinological Investigation 28 1019-1023.
17. Jonas JB, Hayler JK, Sofker A & Panda-Jonas S 2001 Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. American Journal of Ophthalmology 131 468-471.
18. Jonas JB, Kreissig I, Sofker A & Degenring RF 2003 Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Archives of Ophthalmology 121 57-61.
19. Keller-Wood ME & Dallman MF 1984 Corticosteroid inhibition of ACTH secretion. Endocrine Reviews 5 1-24.
20. Kemppainen RJ, Lorenz MD & Thompson FN 1982 Adrenocortical suppression in the dog given a single intramuscular dose of prednisone or triamcinolone acetonide. American Journal of Veterinary Research 43 204-206.
21. Kumar S, Singh RJ, Reed AM & Lteif AN 2004 Cushing's syndrome after intra-articular and intradermal administration of triamcinolone acetonide in three pediatric patients. Pediatrics 113 1820-1824.
22. Levic Z, Micic D, Nikolic J, Stojisavljevic N, Sokic D, Jankovic S, Kendereski A & Mavra M 1996 Short-term high dose steroid therapy does not affect the hypothalamic-pituitary-adrenal axis in relapsing multiple sclerosis patients. Clinical assessment by the insulin tolerance test. Journal of Endocrinological Investigation 19 30-34.
23. Livanou T, Ferriman D & James VH 1967 Recovery of hypothalamo-pituitary-adrenal function after corticosteroid therapy. Lancet 2 856-859.
24. Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, Caulin C & Gaudric A 2004 Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 111 218-224.
25. Mikhail GR, Livingood CS, Mellinger RC, Paige TN & Salyer HL 1969 Effect of long-acting parenteral corticosteroids on adrenal function. Archives of Dermatology 100 263-268.
26. Mikhail GR, Sweet LC & Mellinger RC 1973 Parenteral long-acting corticosteroids: effect on hypothalamic-pituitary-adrenal function. Annals of Allergy 31 337-343.
27. Miyamoto T, Yoshida T, Osawa N & Mizuno K 1972 Adrenal response and side reactions after long-term corticosteroid therapy in bronchial asthma. Annals of Allergy 30 587-594.
28. Möllmann H, Rohdewald P, Schmidt EW, Salomon V & Derendorf H 1985 Pharmacokinetics of triamcinolone acetonide and its phosphate ester. European Journal of Clinical Pharmacology 29 85-89.
29. Morimoto Y, Oishi T, Hanasaki N, Miyatake A, Noma K & Yamamura Y 1980 Relative potency in acute and chronic suppressive effects of prednisolone and betamethasone on the hypothalamic-pituitary-adrenal axis in man. Endocrinologia Japonica 27 659-666.
30. Neu I, Reusche E & Rodiek S 1978 Endogenous cortisol levels after intrathecal injection of triamicinolone acetonide in patients with neurological disease (author's transl). Deutsche Medizinische Wochenschrift 103 1368-1370.
31. Roberts WN, Babcock EA, Breitbach SA, Owen DS & Irby WR 1996 Corticosteroid injection in rheumatoid arthritis does not increase rate of total joint arthroplasty. Journal of Rheumatology 23 1001-1004.
32. Rohatagi S, Hochhaus G, Möllmann H, Barth J, Galia E, Erdmann M, Sourgens H & Derendorf H 1995 Pharmacokinetic and pharmacodynamic evaluation of triamicinolone acetonide after intravenous, oral, and inhaled administration. Journal of Clinical Pharmacology 35 1187-1193.
33. Scher RK 1964 Triamcinolone acetonide intramuscularly: effective long-acting steroid therapy in dermatologic disorders. Journal of the American Geriatrics Society 12 328-336.
34. Skoner DP, Gentile D, Angelini B, Kane R, Birdsall D & Banerji D 2003 The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis. Annals of Allergy, Asthma and Immunology 90 56-62.
35. Sorkness CA, LaForce C, Storms W, Lincourt WR, Edwards L & Rogenes PR 1999 Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma. Clinical Therapeutics 21 353-367.
36. Trotter JL & Garvey WF 1980 Prolonged effects of large-dose methylprednisolone infusion in multiple sclerosis. Neurology 30 702-708.
37. Tuft L, Marks AD & Channick BJ 1971 Long-term corticosteroid therapy in chronic intractable asthmatic patients. Annals of Allergy 29 287-293.
38. Zaloga GP & Marik P 2001 Hypothalamic-pituitary-adrenal insufficiency. Critical Care Clinics 17 25-41.